- Investing Ideas
- U.S. Pharmaceuticals & Biotech Undervalued Small Caps
U.S. Pharmaceuticals & Biotech Undervalued Small Caps
Results
2
0 new
Undervalued Small Caps
2 companies
Abeona Therapeutics
Market Cap: US$412.6m
A commercial-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases in the United States.
ABEO
US$7.24
7D
12.8%
1Y
15.7%
Zevra Therapeutics
Market Cap: US$686.5m
A commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States.
ZVRA
US$11.56
7D
21.6%
1Y
-3.8%